This study investigated the frequency of DUOX2/DUOXA2 mutations in borderline bsTSH GIS CH cases from a single British center, and evaluated the biochemical characteristics and requirement for LT4 treatment in this cohort. This evidence concerns the gene DUOX2 and cyclic hematopoiesis.